| Literature DB >> 33125861 |
Guoqiang Chang1, Lei Shi2, Youqiong Ye3, Hailing Shi4, Lixian Zeng2, Shweta Tiwary2, Jason T Huse5, Lei Huo5, Li Ma2, Yongjie Ma6, Sicong Zhang2, Jianwei Zhu2, Victoria Xie7, Peng Li1, Leng Han3, Chuan He8, Suyun Huang9.
Abstract
Brain metastasis is a major cause of cancer mortality, but its molecular mechanisms are severely understudied. In addition, little is known regarding the role of m6A reader YTHDF3 in human diseases. Here, we show that YTHDF3 overexpression clinically correlates with brain metastases in breast cancer patients. YTHDF3 promotes cancer cell interactions with brain endothelial cells and astrocytes, blood-brain barrier extravasation, angiogenesis, and outgrow. Mechanistically, YTHDF3 enhances the translation of m6A-enriched transcripts for ST6GALNAC5, GJA1, and EGFR, all associated with brain metastasis. Furthermore, overexpression of YTHDF3 in brain metastases is attributed to increased gene copy number and the autoregulation of YTHDF3 cap-independent translation by binding to m6A residues within its own 5' UTR. Our work uncovers an essential role of YTHDF3 in controlling the interaction between cancer cells and brain microenvironment, thereby inducing brain metastatic competence.Entities:
Keywords: YTHDF3; brain metastasis; epigenetic regulation; gene amplification; m(6)A RNA methylation
Mesh:
Substances:
Year: 2020 PMID: 33125861 PMCID: PMC7738369 DOI: 10.1016/j.ccell.2020.10.004
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743